Rank | Gene Set | Z-score |
---|---|---|
1 | polyketide metabolic process (GO:0030638) | 9.16574014 |
2 | doxorubicin metabolic process (GO:0044598) | 9.16574014 |
3 | daunorubicin metabolic process (GO:0044597) | 9.16574014 |
4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.99525930 |
5 | protein localization to kinetochore (GO:0034501) | 5.95283690 |
6 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.62122258 |
7 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.44263195 |
8 | maintenance of protein location in nucleus (GO:0051457) | 5.40264510 |
9 | DNA replication-dependent nucleosome organization (GO:0034723) | 5.11460358 |
10 | DNA replication-dependent nucleosome assembly (GO:0006335) | 5.11460358 |
11 | mitotic sister chromatid segregation (GO:0000070) | 5.08849156 |
12 | cullin deneddylation (GO:0010388) | 5.06000732 |
13 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.04419523 |
14 | negative regulation of telomerase activity (GO:0051974) | 4.97189811 |
15 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.96492299 |
16 | rRNA transcription (GO:0009303) | 4.95950301 |
17 | regulation of response to osmotic stress (GO:0047484) | 4.89920291 |
18 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.88367543 |
19 | negative regulation of epidermis development (GO:0045683) | 4.85489111 |
20 | DNA replication checkpoint (GO:0000076) | 4.84479259 |
21 | regulation of cilium movement (GO:0003352) | 4.80950112 |
22 | rRNA modification (GO:0000154) | 4.76117745 |
23 | rRNA methylation (GO:0031167) | 4.73730569 |
24 | protein localization to chromosome, centromeric region (GO:0071459) | 4.67891710 |
25 | protein deneddylation (GO:0000338) | 4.65691657 |
26 | histone H4-K8 acetylation (GO:0043982) | 4.63938010 |
27 | histone H4-K5 acetylation (GO:0043981) | 4.63938010 |
28 | histone H4-K12 acetylation (GO:0043983) | 4.62634523 |
29 | proteasome assembly (GO:0043248) | 4.58988232 |
30 | somite rostral/caudal axis specification (GO:0032525) | 4.57420390 |
31 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.55705428 |
32 | ribosomal large subunit biogenesis (GO:0042273) | 4.53337073 |
33 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.27582210 |
34 | formation of translation preinitiation complex (GO:0001731) | 4.24512401 |
35 | heterochromatin organization (GO:0070828) | 4.21554213 |
36 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.17561878 |
37 | regulation of translation in response to stress (GO:0043555) | 4.16430226 |
38 | sister chromatid segregation (GO:0000819) | 4.16076162 |
39 | ribosomal small subunit assembly (GO:0000028) | 4.15116568 |
40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.14012637 |
41 | negative regulation of telomere maintenance (GO:0032205) | 4.13448019 |
42 | quinone metabolic process (GO:1901661) | 4.11592040 |
43 | ribosome assembly (GO:0042255) | 4.07800494 |
44 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.07067742 |
45 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.05987939 |
46 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.05334426 |
47 | nuclear pore complex assembly (GO:0051292) | 3.99168659 |
48 | ribosome biogenesis (GO:0042254) | 3.98211394 |
49 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.95807536 |
50 | pseudouridine synthesis (GO:0001522) | 3.94969681 |
51 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.92365406 |
52 | negative regulation of ligase activity (GO:0051352) | 3.91846777 |
53 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.91846777 |
54 | muscle organ morphogenesis (GO:0048644) | 3.89001475 |
55 | nuclear pore organization (GO:0006999) | 3.87682956 |
56 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.81539363 |
57 | notochord development (GO:0030903) | 3.78018759 |
58 | chromatin assembly (GO:0031497) | 3.77311918 |
59 | cytidine deamination (GO:0009972) | 3.73525035 |
60 | cytidine metabolic process (GO:0046087) | 3.73525035 |
61 | cytidine catabolic process (GO:0006216) | 3.73525035 |
62 | DNA damage response, detection of DNA damage (GO:0042769) | 3.73083953 |
63 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.72252025 |
64 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.71383557 |
65 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.71383557 |
66 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.71176907 |
67 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.71176907 |
68 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.71176907 |
69 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.67322709 |
70 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.67322709 |
71 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.66892434 |
72 | ribosomal small subunit biogenesis (GO:0042274) | 3.64574328 |
73 | DNA replication initiation (GO:0006270) | 3.60983342 |
74 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.59277448 |
75 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.58943343 |
76 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.57701469 |
77 | purine nucleobase biosynthetic process (GO:0009113) | 3.57265757 |
78 | tRNA aminoacylation for protein translation (GO:0006418) | 3.54710776 |
79 | positive regulation of ligase activity (GO:0051351) | 3.54658830 |
80 | maturation of SSU-rRNA (GO:0030490) | 3.53976106 |
81 | DNA unwinding involved in DNA replication (GO:0006268) | 3.53241131 |
82 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.52957538 |
83 | tRNA aminoacylation (GO:0043039) | 3.51356515 |
84 | amino acid activation (GO:0043038) | 3.51356515 |
85 | regulation of translational fidelity (GO:0006450) | 3.51020274 |
86 | cotranslational protein targeting to membrane (GO:0006613) | 3.50525983 |
87 | viral transcription (GO:0019083) | 3.49237522 |
88 | protein targeting to ER (GO:0045047) | 3.47401238 |
89 | ATP synthesis coupled proton transport (GO:0015986) | 3.45723412 |
90 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.45723412 |
91 | translational termination (GO:0006415) | 3.45200392 |
92 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.44954469 |
93 | establishment of integrated proviral latency (GO:0075713) | 3.44501272 |
94 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.43480315 |
95 | nucleoside transmembrane transport (GO:1901642) | 3.43454129 |
96 | translational initiation (GO:0006413) | 3.39547437 |
97 | oxidative phosphorylation (GO:0006119) | 3.39378725 |
98 | nucleobase biosynthetic process (GO:0046112) | 3.38827919 |
99 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.36889725 |
100 | translation (GO:0006412) | 3.35472533 |
101 | protein localization to endoplasmic reticulum (GO:0070972) | 3.34027008 |
102 | GDP-mannose metabolic process (GO:0019673) | 3.33621923 |
103 | DNA strand elongation (GO:0022616) | 3.33360905 |
104 | histone H4-K16 acetylation (GO:0043984) | 3.32898990 |
105 | mitotic chromosome condensation (GO:0007076) | 3.32769134 |
106 | histone arginine methylation (GO:0034969) | 3.29424965 |
107 | transcription from mitochondrial promoter (GO:0006390) | 3.28354345 |
108 | regulation of mitochondrial translation (GO:0070129) | 3.26413161 |
109 | regulation of telomerase activity (GO:0051972) | 3.24616954 |
110 | rRNA processing (GO:0006364) | 3.24496514 |
111 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.24104339 |
112 | DNA duplex unwinding (GO:0032508) | 3.23714985 |
113 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.23674683 |
114 | DNA geometric change (GO:0032392) | 3.21349657 |
115 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.21003286 |
116 | microtubule severing (GO:0051013) | 3.19899706 |
117 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.19642288 |
118 | translational elongation (GO:0006414) | 3.17154279 |
119 | regulation of ligase activity (GO:0051340) | 3.15289924 |
120 | protein polyglutamylation (GO:0018095) | 3.11502327 |
121 | regulation of telomere maintenance (GO:0032204) | 3.09854236 |
122 | coenzyme catabolic process (GO:0009109) | 3.09241492 |
123 | termination of RNA polymerase III transcription (GO:0006386) | 3.08784185 |
124 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.08784185 |
125 | rRNA metabolic process (GO:0016072) | 3.08083016 |
126 | primitive streak formation (GO:0090009) | 3.04911268 |
127 | maturation of 5.8S rRNA (GO:0000460) | 3.01492028 |
128 | cell cycle G1/S phase transition (GO:0044843) | 3.00776234 |
129 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.00776234 |
130 | phenol-containing compound catabolic process (GO:0019336) | 3.00284987 |
131 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.00282924 |
132 | regulation of microtubule-based movement (GO:0060632) | 3.00187735 |
133 | respiratory electron transport chain (GO:0022904) | 3.00072458 |
134 | pore complex assembly (GO:0046931) | 2.98984453 |
135 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.98898052 |
136 | regulation of gene silencing by miRNA (GO:0060964) | 2.98898052 |
137 | regulation of gene silencing by RNA (GO:0060966) | 2.98898052 |
138 | tricarboxylic acid cycle (GO:0006099) | 2.98724366 |
139 | protein targeting to mitochondrion (GO:0006626) | 2.98322940 |
140 | spliceosomal snRNP assembly (GO:0000387) | 2.96696307 |
141 | response to dietary excess (GO:0002021) | 2.96298396 |
142 | regulation of double-strand break repair (GO:2000779) | 2.95510981 |
143 | mitochondrial RNA metabolic process (GO:0000959) | 2.95262094 |
144 | electron transport chain (GO:0022900) | 2.94218009 |
145 | cellular component biogenesis (GO:0044085) | 2.94086766 |
146 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.94065453 |
147 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.93628518 |
148 | positive regulation of cell cycle arrest (GO:0071158) | 2.92139069 |
149 | interferon-gamma production (GO:0032609) | 2.91459305 |
150 | maintenance of protein localization in organelle (GO:0072595) | 2.90426145 |
151 | Golgi transport vesicle coating (GO:0048200) | 2.86855274 |
152 | COPI coating of Golgi vesicle (GO:0048205) | 2.86855274 |
153 | cardiovascular system development (GO:0072358) | 2.86562994 |
154 | viral life cycle (GO:0019058) | 2.85707299 |
155 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.84593260 |
156 | regulation of cellular amine metabolic process (GO:0033238) | 2.84265070 |
157 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.83753431 |
158 | regulation of DNA-dependent DNA replication (GO:0090329) | 2.83306462 |
159 | histone H2A acetylation (GO:0043968) | 2.82681576 |
160 | mitotic metaphase plate congression (GO:0007080) | 2.82162187 |
161 | mitotic nuclear envelope disassembly (GO:0007077) | 2.81895271 |
162 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.81137316 |
163 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.79386854 |
164 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.79317686 |
165 | tetrahydrofolate metabolic process (GO:0046653) | 2.79265505 |
166 | establishment of viral latency (GO:0019043) | 2.78390473 |
167 | folic acid metabolic process (GO:0046655) | 2.77162672 |
168 | telomere maintenance via recombination (GO:0000722) | 2.76999324 |
169 | mRNA stabilization (GO:0048255) | 2.76345853 |
170 | RNA stabilization (GO:0043489) | 2.76345853 |
171 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.76173335 |
172 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.75636576 |
173 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.75502987 |
174 | apoptotic DNA fragmentation (GO:0006309) | 2.74932860 |
175 | hormone catabolic process (GO:0042447) | 2.74847741 |
176 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.73317668 |
177 | negative regulation of protein ubiquitination (GO:0031397) | 2.72175868 |
178 | chromosome condensation (GO:0030261) | 2.71551962 |
179 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.71458386 |
180 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.71458386 |
181 | maternal placenta development (GO:0001893) | 2.71155180 |
182 | nuclear envelope disassembly (GO:0051081) | 2.70677119 |
183 | DNA conformation change (GO:0071103) | 2.69059498 |
184 | pre-miRNA processing (GO:0031054) | 2.68432533 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.88549642 |
2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.62595397 |
3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.62595397 |
4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.62595397 |
5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.59065565 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.90155017 |
7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.35361860 |
8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.31900628 |
9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.13188102 |
10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.82162598 |
11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.81487536 |
12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.73760986 |
13 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.67449186 |
14 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.66045618 |
15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.53376134 |
16 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.51089397 |
17 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.44751711 |
18 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.42203638 |
19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.42023576 |
20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.41744294 |
21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.39428212 |
22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.39117783 |
23 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.37272046 |
24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.36826567 |
25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.36599592 |
26 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.36254309 |
27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.23561289 |
28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.15401940 |
29 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.12567063 |
30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.12217622 |
31 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.04229635 |
32 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.98312825 |
33 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.93512026 |
34 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92516723 |
35 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.88315844 |
36 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.87298225 |
37 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.85873141 |
38 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.85339785 |
39 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.82771248 |
40 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.82581504 |
41 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.82270454 |
42 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.81243907 |
43 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.78042756 |
44 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.74868329 |
45 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.72056348 |
46 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.64445986 |
47 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.64314841 |
48 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.63401639 |
49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.62173891 |
50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.60431115 |
51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.59849417 |
52 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.58768455 |
53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.58742396 |
54 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56239899 |
55 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.51614354 |
56 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.51301862 |
57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50309173 |
58 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.49128733 |
59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48367891 |
60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.44395895 |
61 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.41065809 |
62 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.40925740 |
63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.40166794 |
64 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.39992495 |
65 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.39408676 |
66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.39362572 |
67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.38892663 |
68 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.36696727 |
69 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.35284756 |
70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35067054 |
71 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.33341887 |
72 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.32630701 |
73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31861383 |
74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31366336 |
75 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.29975701 |
76 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.29968142 |
77 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28204172 |
78 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.25729831 |
79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24627850 |
80 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.23538510 |
81 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.23205332 |
82 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22691066 |
83 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21826014 |
84 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.18289074 |
85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17262727 |
86 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.17211018 |
87 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.17069536 |
88 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.16520312 |
89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15608363 |
90 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.15283263 |
91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14784602 |
92 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14330949 |
93 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12229720 |
94 | MYC_22102868_ChIP-Seq_BL_Human | 1.10991900 |
95 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10920300 |
96 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.10462903 |
97 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.09837308 |
98 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.09717610 |
99 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.09125202 |
100 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.09104349 |
101 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08767267 |
102 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08233087 |
103 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07353420 |
104 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07070088 |
105 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.05570002 |
106 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05414796 |
107 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05129113 |
108 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04967905 |
109 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04259773 |
110 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00263647 |
111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99819228 |
112 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.99534134 |
113 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98170126 |
114 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.96711531 |
115 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.96193776 |
116 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95963613 |
117 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.95539931 |
118 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91255821 |
119 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.90916657 |
120 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90630256 |
121 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.90362761 |
122 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.89918979 |
123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.89811053 |
124 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.89342397 |
125 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.89154143 |
126 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89065649 |
127 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87164557 |
128 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87029083 |
129 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86987734 |
130 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.85881613 |
131 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.85492203 |
132 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.85174978 |
133 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83987818 |
134 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83636415 |
135 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83222248 |
136 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.83074093 |
137 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.82717740 |
138 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.82561529 |
139 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82344394 |
140 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.82274022 |
141 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.81597047 |
142 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.78818842 |
143 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77576204 |
144 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.76088143 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003011_delayed_dark_adaptation | 4.05652089 |
2 | MP0006292_abnormal_olfactory_placode | 4.05551332 |
3 | MP0004957_abnormal_blastocyst_morpholog | 3.94577369 |
4 | MP0008057_abnormal_DNA_replication | 3.67523166 |
5 | MP0004264_abnormal_extraembryonic_tissu | 3.37031113 |
6 | MP0005499_abnormal_olfactory_system | 3.19615237 |
7 | MP0005394_taste/olfaction_phenotype | 3.19615237 |
8 | MP0003890_abnormal_embryonic-extraembry | 3.08810399 |
9 | MP0002254_reproductive_system_inflammat | 2.87075792 |
10 | MP0005075_abnormal_melanosome_morpholog | 2.84815122 |
11 | MP0003122_maternal_imprinting | 2.79433597 |
12 | MP0009697_abnormal_copulation | 2.57176408 |
13 | MP0003121_genomic_imprinting | 2.50609448 |
14 | MP0010094_abnormal_chromosome_stability | 2.49402267 |
15 | MP0004858_abnormal_nervous_system | 2.47448704 |
16 | MP0002653_abnormal_ependyma_morphology | 2.42114667 |
17 | MP0003077_abnormal_cell_cycle | 2.39866733 |
18 | MP0002332_abnormal_exercise_endurance | 2.39634861 |
19 | MP0003111_abnormal_nucleus_morphology | 2.35963038 |
20 | MP0003718_maternal_effect | 2.25470779 |
21 | MP0003123_paternal_imprinting | 2.21173930 |
22 | MP0005408_hypopigmentation | 2.16463863 |
23 | MP0003693_abnormal_embryo_hatching | 2.12303052 |
24 | * MP0006035_abnormal_mitochondrial_morpho | 2.05863035 |
25 | MP0001661_extended_life_span | 2.01512241 |
26 | MP0001672_abnormal_embryogenesis/_devel | 2.00537198 |
27 | MP0005380_embryogenesis_phenotype | 2.00537198 |
28 | MP0004147_increased_porphyrin_level | 1.96612486 |
29 | MP0003984_embryonic_growth_retardation | 1.84159019 |
30 | MP0002088_abnormal_embryonic_growth/wei | 1.84047157 |
31 | MP0000372_irregular_coat_pigmentation | 1.79191345 |
32 | MP0008932_abnormal_embryonic_tissue | 1.79115870 |
33 | MP0005451_abnormal_body_composition | 1.75426795 |
34 | MP0000350_abnormal_cell_proliferation | 1.74962844 |
35 | MP0000678_abnormal_parathyroid_gland | 1.72740418 |
36 | MP0008995_early_reproductive_senescence | 1.67130523 |
37 | MP0008058_abnormal_DNA_repair | 1.66960044 |
38 | MP0002127_abnormal_cardiovascular_syste | 1.65354310 |
39 | MP0010352_gastrointestinal_tract_polyps | 1.63090809 |
40 | MP0008789_abnormal_olfactory_epithelium | 1.58935476 |
41 | MP0009333_abnormal_splenocyte_physiolog | 1.57361186 |
42 | MP0005257_abnormal_intraocular_pressure | 1.57082608 |
43 | MP0001730_embryonic_growth_arrest | 1.56769708 |
44 | MP0001293_anophthalmia | 1.55389040 |
45 | MP0005266_abnormal_metabolism | 1.52949871 |
46 | MP0003938_abnormal_ear_development | 1.52219728 |
47 | MP0004133_heterotaxia | 1.50559162 |
48 | MP0001727_abnormal_embryo_implantation | 1.49605564 |
49 | MP0006036_abnormal_mitochondrial_physio | 1.49353451 |
50 | MP0001764_abnormal_homeostasis | 1.47795019 |
51 | MP0002085_abnormal_embryonic_tissue | 1.47639193 |
52 | MP0004233_abnormal_muscle_weight | 1.46962960 |
53 | MP0010234_abnormal_vibrissa_follicle | 1.45451235 |
54 | MP0003705_abnormal_hypodermis_morpholog | 1.41354566 |
55 | MP0002166_altered_tumor_susceptibility | 1.39113919 |
56 | MP0005410_abnormal_fertilization | 1.38341434 |
57 | MP0001849_ear_inflammation | 1.35802069 |
58 | MP0001881_abnormal_mammary_gland | 1.34725199 |
59 | MP0010307_abnormal_tumor_latency | 1.31869457 |
60 | MP0000049_abnormal_middle_ear | 1.28102591 |
61 | MP0008007_abnormal_cellular_replicative | 1.27958841 |
62 | MP0003315_abnormal_perineum_morphology | 1.27420503 |
63 | MP0004808_abnormal_hematopoietic_stem | 1.25969616 |
64 | MP0010030_abnormal_orbit_morphology | 1.25875682 |
65 | * MP0002086_abnormal_extraembryonic_tissu | 1.24840641 |
66 | MP0001873_stomach_inflammation | 1.24062270 |
67 | MP0002396_abnormal_hematopoietic_system | 1.23927825 |
68 | MP0003787_abnormal_imprinting | 1.23472765 |
69 | * MP0002084_abnormal_developmental_patter | 1.22869052 |
70 | MP0003806_abnormal_nucleotide_metabolis | 1.21276193 |
71 | MP0003941_abnormal_skin_development | 1.21002726 |
72 | MP0002932_abnormal_joint_morphology | 1.16795492 |
73 | MP0002277_abnormal_respiratory_mucosa | 1.16592703 |
74 | * MP0002080_prenatal_lethality | 1.16442500 |
75 | MP0000749_muscle_degeneration | 1.15711368 |
76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.15626969 |
77 | MP0002006_tumorigenesis | 1.14749772 |
78 | MP0003137_abnormal_impulse_conducting | 1.13954433 |
79 | * MP0001697_abnormal_embryo_size | 1.13730148 |
80 | MP0003119_abnormal_digestive_system | 1.13466725 |
81 | MP0002092_abnormal_eye_morphology | 1.12517707 |
82 | MP0001853_heart_inflammation | 1.11705681 |
83 | * MP0000313_abnormal_cell_death | 1.11682330 |
84 | MP0003786_premature_aging | 1.11052816 |
85 | MP0005501_abnormal_skin_physiology | 1.10982166 |
86 | MP0004197_abnormal_fetal_growth/weight/ | 1.08462273 |
87 | MP0000490_abnormal_crypts_of | 1.07654815 |
88 | MP0002269_muscular_atrophy | 1.07034232 |
89 | MP0002114_abnormal_axial_skeleton | 1.06980502 |
90 | MP0004043_abnormal_pH_regulation | 1.06309173 |
91 | MP0005083_abnormal_biliary_tract | 1.03243903 |
92 | MP0005332_abnormal_amino_acid | 1.02311069 |
93 | MP0003656_abnormal_erythrocyte_physiolo | 1.01961815 |
94 | MP0002751_abnormal_autonomic_nervous | 1.01561186 |
95 | MP0002233_abnormal_nose_morphology | 1.01493391 |
96 | MP0000762_abnormal_tongue_morphology | 1.01196362 |
97 | MP0002163_abnormal_gland_morphology | 1.00398166 |
98 | MP0001348_abnormal_lacrimal_gland | 1.00183064 |
99 | MP0005319_abnormal_enzyme/_coenzyme | 0.98831101 |
100 | MP0001145_abnormal_male_reproductive | 0.98813831 |
101 | MP0008961_abnormal_basal_metabolism | 0.98257426 |
102 | MP0002970_abnormal_white_adipose | 0.95626186 |
103 | MP0000609_abnormal_liver_physiology | 0.94572572 |
104 | MP0004782_abnormal_surfactant_physiolog | 0.92930204 |
105 | MP0002132_abnormal_respiratory_system | 0.92718625 |
106 | MP0002796_impaired_skin_barrier | 0.92613194 |
107 | MP0001545_abnormal_hematopoietic_system | 0.92167001 |
108 | MP0005397_hematopoietic_system_phenotyp | 0.92167001 |
109 | MP0009672_abnormal_birth_weight | 0.92012268 |
110 | MP0001929_abnormal_gametogenesis | 0.91666706 |
111 | MP0008770_decreased_survivor_rate | 0.89679973 |
112 | MP0000428_abnormal_craniofacial_morphol | 0.89493024 |
113 | MP0002210_abnormal_sex_determination | 0.88706249 |
114 | MP0000750_abnormal_muscle_regeneration | 0.88643655 |
115 | MP0000627_abnormal_mammary_gland | 0.87633949 |
116 | * MP0000358_abnormal_cell_content/ | 0.86637783 |
117 | MP0008877_abnormal_DNA_methylation | 0.86283251 |
118 | MP0005379_endocrine/exocrine_gland_phen | 0.86098417 |
119 | MP0009840_abnormal_foam_cell | 0.85613832 |
120 | MP0005395_other_phenotype | 0.84187032 |
121 | MP0005670_abnormal_white_adipose | 0.83658723 |
122 | MP0003183_abnormal_peptide_metabolism | 0.83043711 |
123 | MP0003136_yellow_coat_color | 0.83031434 |
124 | MP0001529_abnormal_vocalization | 0.82226682 |
125 | MP0003698_abnormal_male_reproductive | 0.81908767 |
126 | MP0002877_abnormal_melanocyte_morpholog | 0.81667914 |
127 | MP0000432_abnormal_head_morphology | 0.80974057 |
128 | MP0001216_abnormal_epidermal_layer | 0.80735268 |
129 | MP0003186_abnormal_redox_activity | 0.79781997 |
130 | MP0000647_abnormal_sebaceous_gland | 0.78283065 |
131 | MP0003950_abnormal_plasma_membrane | 0.77946869 |
132 | MP0003755_abnormal_palate_morphology | 0.77783652 |
133 | MP0000598_abnormal_liver_morphology | 0.77762047 |
134 | MP0003763_abnormal_thymus_physiology | 0.77377524 |
135 | MP0003935_abnormal_craniofacial_develop | 0.76404446 |
136 | MP0003943_abnormal_hepatobiliary_system | 0.76355003 |
137 | MP0005636_abnormal_mineral_homeostasis | 0.75470975 |
138 | MP0005391_vision/eye_phenotype | 0.74794283 |
139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73548338 |
140 | MP0005389_reproductive_system_phenotype | 0.72875850 |
141 | MP0005058_abnormal_lysosome_morphology | 0.70451632 |
142 | MP0000427_abnormal_hair_cycle | 0.67101953 |
143 | MP0002019_abnormal_tumor_incidence | 0.66764495 |
144 | MP0003283_abnormal_digestive_organ | 0.65891176 |
145 | MP0005220_abnormal_exocrine_pancreas | 0.64882922 |
146 | MP0003861_abnormal_nervous_system | 0.64812776 |
147 | MP0003646_muscle_fatigue | 0.64764050 |
148 | MP0000653_abnormal_sex_gland | 0.63161101 |
149 | MP0002116_abnormal_craniofacial_bone | 0.63149852 |
150 | MP0000703_abnormal_thymus_morphology | 0.63082710 |
151 | MP0009703_decreased_birth_body | 0.63047904 |
152 | MP0002160_abnormal_reproductive_system | 0.62796357 |
153 | MP0005330_cardiomyopathy | 0.62768215 |
154 | MP0002060_abnormal_skin_morphology | 0.62277771 |
155 | * MP0005384_cellular_phenotype | 0.61810571 |
156 | MP0001919_abnormal_reproductive_system | 0.61465807 |
157 | MP0003937_abnormal_limbs/digits/tail_de | 0.60135422 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Bilateral microphthalmos (HP:0007633) | 6.53975443 |
2 | Multiple enchondromatosis (HP:0005701) | 5.26030579 |
3 | Hypochromic microcytic anemia (HP:0004840) | 5.11737030 |
4 | Abnormality of the lower motor neuron (HP:0002366) | 4.60375039 |
5 | Hepatoblastoma (HP:0002884) | 4.43683900 |
6 | Ependymoma (HP:0002888) | 4.32647407 |
7 | Acute encephalopathy (HP:0006846) | 4.25110201 |
8 | Acute necrotizing encephalopathy (HP:0006965) | 4.14875179 |
9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.11851849 |
10 | Rib fusion (HP:0000902) | 3.91741415 |
11 | Increased CSF lactate (HP:0002490) | 3.89073897 |
12 | Hepatic necrosis (HP:0002605) | 3.77996811 |
13 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.75343579 |
14 | Rhabdomyosarcoma (HP:0002859) | 3.67578781 |
15 | Mitochondrial inheritance (HP:0001427) | 3.67183078 |
16 | Hepatocellular necrosis (HP:0001404) | 3.66788320 |
17 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.64281983 |
18 | Neoplasm of striated muscle (HP:0009728) | 3.63519078 |
19 | Ragged-red muscle fibers (HP:0003200) | 3.62879429 |
20 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.53450992 |
21 | Testicular atrophy (HP:0000029) | 3.51421295 |
22 | Embryonal renal neoplasm (HP:0011794) | 3.46322573 |
23 | Reticulocytopenia (HP:0001896) | 3.38481033 |
24 | Abnormal number of erythroid precursors (HP:0012131) | 3.34795976 |
25 | Abnormality of glycolysis (HP:0004366) | 3.34594749 |
26 | Increased serum pyruvate (HP:0003542) | 3.34594749 |
27 | Increased serum lactate (HP:0002151) | 3.34216569 |
28 | Progressive macrocephaly (HP:0004481) | 3.33243595 |
29 | Abnormality of methionine metabolism (HP:0010901) | 3.33003290 |
30 | Chromsome breakage (HP:0040012) | 3.28390341 |
31 | Cerebral edema (HP:0002181) | 3.27059682 |
32 | Generalized aminoaciduria (HP:0002909) | 3.19308347 |
33 | Abnormal lung lobation (HP:0002101) | 3.14754722 |
34 | Increased hepatocellular lipid droplets (HP:0006565) | 3.09627831 |
35 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.03919344 |
36 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.03919344 |
37 | Rectal fistula (HP:0100590) | 3.03850328 |
38 | Rectovaginal fistula (HP:0000143) | 3.03850328 |
39 | Lactic acidosis (HP:0003128) | 3.02478773 |
40 | Lipid accumulation in hepatocytes (HP:0006561) | 3.01736469 |
41 | Supernumerary spleens (HP:0009799) | 2.97119188 |
42 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.97103804 |
43 | Hypoplasia of the fovea (HP:0007750) | 2.97103804 |
44 | Abnormality of the astrocytes (HP:0100707) | 2.95849961 |
45 | Astrocytoma (HP:0009592) | 2.95849961 |
46 | Trismus (HP:0000211) | 2.91233772 |
47 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.89367656 |
48 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.89367656 |
49 | Abnormal protein glycosylation (HP:0012346) | 2.89367656 |
50 | Abnormal glycosylation (HP:0012345) | 2.89367656 |
51 | 3-Methylglutaconic aciduria (HP:0003535) | 2.85294957 |
52 | Bifid tongue (HP:0010297) | 2.83044680 |
53 | Meckel diverticulum (HP:0002245) | 2.82369330 |
54 | Microvesicular hepatic steatosis (HP:0001414) | 2.81294427 |
55 | Amyotrophic lateral sclerosis (HP:0007354) | 2.77264130 |
56 | Macrocytic anemia (HP:0001972) | 2.72538441 |
57 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.71984070 |
58 | Fused cervical vertebrae (HP:0002949) | 2.71057596 |
59 | Abnormality of the anterior horn cell (HP:0006802) | 2.68178042 |
60 | Degeneration of anterior horn cells (HP:0002398) | 2.68178042 |
61 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.67764241 |
62 | Progressive muscle weakness (HP:0003323) | 2.67702569 |
63 | Respiratory failure (HP:0002878) | 2.66518517 |
64 | Abnormality of the ileum (HP:0001549) | 2.65055578 |
65 | Cholecystitis (HP:0001082) | 2.63226483 |
66 | Abnormal gallbladder physiology (HP:0012438) | 2.63226483 |
67 | Increased intramyocellular lipid droplets (HP:0012240) | 2.59859325 |
68 | Hyperalaninemia (HP:0003348) | 2.59697054 |
69 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59697054 |
70 | Abnormality of alanine metabolism (HP:0010916) | 2.59697054 |
71 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.59490247 |
72 | Partial duplication of thumb phalanx (HP:0009944) | 2.59236613 |
73 | Premature ovarian failure (HP:0008209) | 2.58095115 |
74 | Tongue fasciculations (HP:0001308) | 2.57174403 |
75 | Abnormality of the salivary glands (HP:0010286) | 2.56316147 |
76 | Intestinal fistula (HP:0100819) | 2.55766683 |
77 | Birth length less than 3rd percentile (HP:0003561) | 2.53576431 |
78 | Anomalous pulmonary venous return (HP:0010772) | 2.52393361 |
79 | Horizontal nystagmus (HP:0000666) | 2.51847890 |
80 | Vaginal fistula (HP:0004320) | 2.51698440 |
81 | Reduced antithrombin III activity (HP:0001976) | 2.51408897 |
82 | Microretrognathia (HP:0000308) | 2.50501782 |
83 | Short humerus (HP:0005792) | 2.50304513 |
84 | Sparse eyelashes (HP:0000653) | 2.49915644 |
85 | Impulsivity (HP:0100710) | 2.49158067 |
86 | Exercise intolerance (HP:0003546) | 2.48728787 |
87 | Aplastic anemia (HP:0001915) | 2.46133357 |
88 | Abnormal cartilage morphology (HP:0002763) | 2.44993486 |
89 | Renal Fanconi syndrome (HP:0001994) | 2.42632092 |
90 | Progressive external ophthalmoplegia (HP:0000590) | 2.41699228 |
91 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.40650270 |
92 | CNS demyelination (HP:0007305) | 2.39841352 |
93 | Lethargy (HP:0001254) | 2.38216337 |
94 | Respiratory difficulties (HP:0002880) | 2.36831309 |
95 | Facial cleft (HP:0002006) | 2.36638924 |
96 | Pancytopenia (HP:0001876) | 2.33211898 |
97 | Muscle fibrillation (HP:0010546) | 2.32896872 |
98 | Hyperammonemia (HP:0001987) | 2.32786440 |
99 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.32546541 |
100 | Partial duplication of the phalanx of hand (HP:0009999) | 2.30583437 |
101 | Hyperventilation (HP:0002883) | 2.29364351 |
102 | Glossoptosis (HP:0000162) | 2.28508122 |
103 | Increased muscle lipid content (HP:0009058) | 2.27171719 |
104 | Generalized hypotonia (HP:0001290) | 2.26216642 |
105 | Glioma (HP:0009733) | 2.25163462 |
106 | Abnormality of the fovea (HP:0000493) | 2.24756444 |
107 | Sensory axonal neuropathy (HP:0003390) | 2.23605324 |
108 | Preauricular skin tag (HP:0000384) | 2.23097994 |
109 | Medulloblastoma (HP:0002885) | 2.22964777 |
110 | Duodenal stenosis (HP:0100867) | 2.21692169 |
111 | Small intestinal stenosis (HP:0012848) | 2.21692169 |
112 | Cerebral hypomyelination (HP:0006808) | 2.21126589 |
113 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.20912371 |
114 | Angiofibromas (HP:0010615) | 2.20550482 |
115 | Adenoma sebaceum (HP:0009720) | 2.20550482 |
116 | Type I transferrin isoform profile (HP:0003642) | 2.19871044 |
117 | Hypokinesia (HP:0002375) | 2.19759207 |
118 | Neoplasm of head and neck (HP:0012288) | 2.17584030 |
119 | Esophageal neoplasm (HP:0100751) | 2.17584030 |
120 | Shawl scrotum (HP:0000049) | 2.17014272 |
121 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.16687529 |
122 | Nausea (HP:0002018) | 2.14764331 |
123 | Hypobetalipoproteinemia (HP:0003563) | 2.13503906 |
124 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.10692151 |
125 | Abnormality of the pulmonary veins (HP:0011718) | 2.09687342 |
126 | Missing ribs (HP:0000921) | 2.09253583 |
127 | Spastic paraparesis (HP:0002313) | 2.08915230 |
128 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.08806793 |
129 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.06385409 |
130 | Overlapping toe (HP:0001845) | 2.06272378 |
131 | Abnormality of serum amino acid levels (HP:0003112) | 2.06254906 |
132 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.06154282 |
133 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.06130388 |
134 | Pallor (HP:0000980) | 2.05680302 |
135 | Hypochromic anemia (HP:0001931) | 2.05517379 |
136 | Abnormality of chromosome segregation (HP:0002916) | 2.04413567 |
137 | Leukodystrophy (HP:0002415) | 2.04275935 |
138 | Pendular nystagmus (HP:0012043) | 2.03124759 |
139 | Rough bone trabeculation (HP:0100670) | 2.02973761 |
140 | Abnormality of the preputium (HP:0100587) | 2.01605683 |
141 | Tetraplegia (HP:0002445) | 2.00322401 |
142 | Squamous cell carcinoma (HP:0002860) | 1.99601878 |
143 | Palpitations (HP:0001962) | 1.96904742 |
144 | Secondary amenorrhea (HP:0000869) | 1.95416489 |
145 | Abnormality of reticulocytes (HP:0004312) | 1.94846546 |
146 | Sloping forehead (HP:0000340) | 1.94220258 |
147 | Abnormality of placental membranes (HP:0011409) | 1.93519762 |
148 | Amniotic constriction ring (HP:0009775) | 1.93519762 |
149 | Abnormality of chromosome stability (HP:0003220) | 1.93140170 |
150 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.92387559 |
151 | Nasolacrimal duct obstruction (HP:0000579) | 1.89880888 |
152 | Skin tags (HP:0010609) | 1.89851189 |
153 | Preauricular pit (HP:0004467) | 1.89603076 |
154 | Periauricular skin pits (HP:0100277) | 1.89603076 |
155 | Abnormality of urine glucose concentration (HP:0011016) | 1.88976739 |
156 | Glycosuria (HP:0003076) | 1.88976739 |
157 | Absent thumb (HP:0009777) | 1.87974141 |
158 | Myelodysplasia (HP:0002863) | 1.87628226 |
159 | Hypoglycemic coma (HP:0001325) | 1.86802002 |
160 | Neoplasm of the adrenal gland (HP:0100631) | 1.84733388 |
161 | Fasciculations (HP:0002380) | 1.84193317 |
162 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.84083115 |
163 | Atresia of the external auditory canal (HP:0000413) | 1.83882095 |
164 | Oral leukoplakia (HP:0002745) | 1.83866407 |
165 | CNS hypomyelination (HP:0003429) | 1.82920216 |
166 | Homocystinuria (HP:0002156) | 1.82667909 |
167 | Abnormality of homocysteine metabolism (HP:0010919) | 1.82667909 |
168 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.82227047 |
169 | Increased connective tissue (HP:0009025) | 1.82188022 |
170 | Large earlobe (HP:0009748) | 1.81999452 |
171 | Entropion (HP:0000621) | 1.81680771 |
172 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.81267471 |
173 | Villous atrophy (HP:0011473) | 1.81267471 |
174 | Optic disc pallor (HP:0000543) | 1.80767725 |
175 | Posterior subcapsular cataract (HP:0007787) | 1.80433364 |
176 | Rhabdomyolysis (HP:0003201) | 1.79850007 |
177 | Renal cortical cysts (HP:0000803) | 1.79435903 |
178 | Difficulty running (HP:0009046) | 1.79420113 |
179 | Abnormality of the duodenum (HP:0002246) | 1.78936596 |
180 | Abnormality of the labia minora (HP:0012880) | 1.78409505 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 7.69571618 |
2 | GRK5 | 4.70486163 |
3 | PBK | 4.06984767 |
4 | GRK6 | 3.94760141 |
5 | ERN1 | 3.63015062 |
6 | TTK | 3.18163423 |
7 | VRK2 | 3.12127261 |
8 | ADRBK2 | 2.76776457 |
9 | GRK1 | 2.65914926 |
10 | CSF1R | 2.40320191 |
11 | GRK7 | 2.25686656 |
12 | SCYL2 | 2.25683667 |
13 | BUB1 | 2.25342535 |
14 | TYRO3 | 2.17991458 |
15 | MST1R | 2.04558472 |
16 | TRIM28 | 1.96785166 |
17 | MAPK7 | 1.93333853 |
18 | STK10 | 1.92115762 |
19 | MAP3K12 | 1.90362128 |
20 | TGFBR2 | 1.89992732 |
21 | WEE1 | 1.89062748 |
22 | CDC7 | 1.86982343 |
23 | MATK | 1.83930885 |
24 | MOS | 1.80827105 |
25 | IRAK3 | 1.76360709 |
26 | CDK7 | 1.76151912 |
27 | PDK3 | 1.73128648 |
28 | PDK4 | 1.73128648 |
29 | SIK3 | 1.71655827 |
30 | AKT3 | 1.71143594 |
31 | PLK1 | 1.67087458 |
32 | ZAK | 1.66721613 |
33 | WNK1 | 1.60768672 |
34 | CHEK2 | 1.57329281 |
35 | PAK4 | 1.38779232 |
36 | NEK1 | 1.31300285 |
37 | EPHA2 | 1.26194395 |
38 | NEK2 | 1.22018809 |
39 | CAMK4 | 1.20311028 |
40 | SRPK1 | 1.17101191 |
41 | PRKG2 | 1.16486086 |
42 | MAP2K4 | 1.12633056 |
43 | CHEK1 | 1.05112995 |
44 | AURKA | 1.04983976 |
45 | ADRBK1 | 1.03527916 |
46 | BMPR1B | 1.02891706 |
47 | EIF2AK1 | 1.01355565 |
48 | TESK2 | 1.00345679 |
49 | TLK1 | 0.98153264 |
50 | SMG1 | 0.94250482 |
51 | DAPK1 | 0.93475380 |
52 | TAF1 | 0.91366721 |
53 | NTRK1 | 0.91288957 |
54 | MET | 0.91158832 |
55 | STK4 | 0.88152480 |
56 | MARK2 | 0.85892363 |
57 | CLK1 | 0.85238464 |
58 | ILK | 0.84853511 |
59 | AKT2 | 0.82792894 |
60 | NME2 | 0.81876365 |
61 | MKNK1 | 0.80518026 |
62 | NUAK1 | 0.79716795 |
63 | PIM2 | 0.79497598 |
64 | MAP2K6 | 0.79465125 |
65 | AURKB | 0.79364914 |
66 | PDK2 | 0.77407424 |
67 | RPS6KB2 | 0.75815357 |
68 | ACVR1B | 0.75294853 |
69 | FLT3 | 0.73712597 |
70 | VRK1 | 0.72229461 |
71 | TESK1 | 0.71938661 |
72 | BMPR2 | 0.71300813 |
73 | DYRK3 | 0.69606742 |
74 | EIF2AK2 | 0.69391102 |
75 | STK16 | 0.67943296 |
76 | PRKCI | 0.67018988 |
77 | BCR | 0.65171919 |
78 | CDK2 | 0.64201131 |
79 | HIPK2 | 0.63750465 |
80 | MAP3K10 | 0.62624454 |
81 | LRRK2 | 0.62265133 |
82 | NME1 | 0.61591660 |
83 | ALK | 0.60508211 |
84 | PAK1 | 0.60232003 |
85 | CDK8 | 0.59771206 |
86 | CDK4 | 0.57862356 |
87 | TGFBR1 | 0.53131956 |
88 | RAF1 | 0.52724962 |
89 | ATM | 0.51410134 |
90 | MAP3K3 | 0.48949070 |
91 | DYRK2 | 0.47946469 |
92 | BRAF | 0.47308484 |
93 | MAPK12 | 0.46790071 |
94 | LATS2 | 0.46379081 |
95 | MAPKAPK3 | 0.45107227 |
96 | MKNK2 | 0.44462293 |
97 | STK3 | 0.44376603 |
98 | EIF2AK3 | 0.44278880 |
99 | ERBB4 | 0.41748596 |
100 | BCKDK | 0.41541853 |
101 | ERBB3 | 0.41424361 |
102 | MAP3K14 | 0.40764740 |
103 | ATR | 0.40746614 |
104 | RPS6KA4 | 0.39270022 |
105 | MYLK | 0.39176710 |
106 | CSNK1E | 0.38961128 |
107 | CDK1 | 0.38702061 |
108 | BRSK2 | 0.34345595 |
109 | KSR1 | 0.33923607 |
110 | MTOR | 0.33689756 |
111 | LMTK2 | 0.33190892 |
112 | BRSK1 | 0.30947137 |
113 | TSSK6 | 0.30877153 |
114 | CDK19 | 0.30094118 |
115 | IKBKB | 0.29463143 |
116 | CDK15 | 0.28214537 |
117 | CDK18 | 0.27613383 |
118 | CSNK1G3 | 0.27085823 |
119 | CDK11A | 0.26660846 |
120 | CSNK2A1 | 0.25979496 |
121 | PASK | 0.25950342 |
122 | CSNK2A2 | 0.25092711 |
123 | MAP2K2 | 0.24269519 |
124 | MST4 | 0.23985605 |
125 | CDK9 | 0.23686697 |
126 | MARK3 | 0.23396014 |
127 | MAP3K7 | 0.22942041 |
128 | PRKCG | 0.22936712 |
129 | MUSK | 0.22552158 |
130 | DAPK3 | 0.22313407 |
131 | EEF2K | 0.22224240 |
132 | MAPKAPK2 | 0.21583898 |
133 | FGFR3 | 0.20921429 |
134 | MAP4K2 | 0.20608614 |
135 | PAK2 | 0.20474769 |
136 | MAPK10 | 0.20380699 |
137 | TAOK2 | 0.20131279 |
138 | CCNB1 | 0.19787208 |
139 | CSK | 0.19778476 |
140 | GSK3B | 0.19120463 |
141 | CDK14 | 0.18579056 |
142 | PLK4 | 0.17073096 |
143 | PLK3 | 0.15138502 |
144 | MAP3K8 | 0.14400588 |
145 | PRKACB | 0.14204440 |
146 | MAP3K9 | 0.13971292 |
147 | MAPK14 | 0.13789316 |
148 | ICK | 0.12556677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.60894782 |
2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.54101855 |
3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.44500517 |
4 | DNA replication_Homo sapiens_hsa03030 | 3.34687152 |
5 | Ribosome_Homo sapiens_hsa03010 | 3.32150210 |
6 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.99131875 |
7 | RNA transport_Homo sapiens_hsa03013 | 2.84850308 |
8 | Mismatch repair_Homo sapiens_hsa03430 | 2.78586169 |
9 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.48439608 |
10 | Proteasome_Homo sapiens_hsa03050 | 2.35643412 |
11 | RNA polymerase_Homo sapiens_hsa03020 | 2.27479734 |
12 | Homologous recombination_Homo sapiens_hsa03440 | 2.21821010 |
13 | Spliceosome_Homo sapiens_hsa03040 | 2.21807618 |
14 | Protein export_Homo sapiens_hsa03060 | 2.07267003 |
15 | Base excision repair_Homo sapiens_hsa03410 | 2.05348211 |
16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.98962715 |
17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.97871122 |
18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.96854580 |
19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.93155122 |
20 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.83350028 |
21 | Cell cycle_Homo sapiens_hsa04110 | 1.81409325 |
22 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.72261201 |
23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.69825016 |
24 | RNA degradation_Homo sapiens_hsa03018 | 1.69356879 |
25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.67829738 |
26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.64776487 |
27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.64573552 |
28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.62007482 |
29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.61948401 |
30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53733598 |
31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.47433047 |
32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.47388054 |
33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.46828755 |
34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.44638594 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41957229 |
36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.41483787 |
37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41463088 |
38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.39021085 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29642490 |
40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.28387217 |
41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27711139 |
42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20798400 |
43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16773749 |
44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.11825597 |
45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11233060 |
46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.01359456 |
47 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.96820319 |
48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96646734 |
49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96265759 |
50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95148994 |
51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88473853 |
52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88219850 |
53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84771233 |
54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84042865 |
55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82439335 |
56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79469205 |
57 | Purine metabolism_Homo sapiens_hsa00230 | 0.78918953 |
58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77281409 |
59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77119264 |
60 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71168253 |
61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68471469 |
62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67605712 |
63 | Peroxisome_Homo sapiens_hsa04146 | 0.65703583 |
64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64104254 |
65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62072463 |
66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60824371 |
67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59860128 |
68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58977756 |
69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56970592 |
70 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56951529 |
71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55558614 |
72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55502858 |
73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52093691 |
74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52061141 |
75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49993842 |
76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49639520 |
77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49185966 |
78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47637530 |
79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44518710 |
80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44326938 |
81 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.42969471 |
82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41848310 |
83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41795496 |
84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40657700 |
85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40623393 |
86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39532912 |
87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35975786 |
88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35409361 |
89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35241032 |
90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35130476 |
91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34551220 |
92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.34176767 |
93 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.32376836 |
94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31869086 |
95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30861684 |
96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30501313 |
97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29979493 |
98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29569940 |
99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.29369148 |
100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28953835 |
101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28917677 |
102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28745091 |
103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28482433 |
104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26011842 |
105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.25616039 |
106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.24948845 |
107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.24805310 |
108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.24771873 |
109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.23021979 |
110 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.22748060 |
111 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.21810154 |
112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.21406671 |
113 | Legionellosis_Homo sapiens_hsa05134 | 0.19413223 |
114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.19197561 |
115 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.17973794 |
116 | Bladder cancer_Homo sapiens_hsa05219 | 0.17622589 |
117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.17580602 |
118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.16777753 |
119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.15920451 |
120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.15445309 |
121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.14436046 |
122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14218415 |
123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.14151082 |
124 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.13153701 |
125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11664604 |
126 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.11003102 |
127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.08929804 |
128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.07777357 |
129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.07772253 |
130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.06985949 |
131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.06469540 |
132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.05578074 |
133 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.05328699 |